Skip to content
healthcare.dev

Panzyga

NDC 0069-1109, immune globulin intravenous (human), solution, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-1109
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
SOLUTION
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125587
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1109 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN IMMUNOGLOBULIN G100 mg/mL

Pharmacologic classes

Antigen Neutralization [MoA]; Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]

Package NDCNDC-11Package
0069-1109-02000691109021 BOTTLE, GLASS in 1 CARTON (0069-1109-02) / 25 mL in 1 BOTTLE, GLASS (0069-1109-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0069-1109

Use it

Look up 0069-1109 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1109 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-1109. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.